Advertisement
Screener

MEDICUS PHARMA LTD. (MDCX) Cash and Restricted Cash

2.8 / 5 stars · 68/120 Roast Me

MEDICUS PHARMA LTD. Cash and Restricted Cash

MEDICUS PHARMA LTD. (MDCX) had Cash and Restricted Cash of $25.19 million as of 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Cash Flow

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-12

  • 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $25.19M.
  • 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.37M.
  • 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8.71M.
  • 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8.66M.
Period endCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
2026-06-30$25.19M
10-Q · filed 2026-08-12
2026-03-31$6.37M
10-Q · filed 2026-05-14
2025-12-31$8.71M
10-Q · filed 2026-08-12
2025-09-30$8.66M
10-Q · filed 2025-11-14
2025-06-30$9.67M
10-Q · filed 2026-08-12
2025-03-31$3.98M
10-Q · filed 2026-05-14
2024-12-31$4.16M
10-Q · filed 2026-08-12
2024-09-30$5.31M
10-Q · filed 2025-11-14
2024-06-30$8.41M
10-Q · filed 2025-08-11
2024-03-31$542.40K
10-Q · filed 2025-05-12
2023-12-31$1.72M
10-K · filed 2026-03-25
2022-12-31$267.65K
10-K · filed 2025-03-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Azitra, Inc. (AZTR)United States$0.010B-0.81
Aprea Therapeutics, Inc. (APRE)United States$0.010B-0.78
Theriva Biologics, Inc. (TOVX)United States$0.011B
KALA BIO, Inc. (KALA)United States$0.011B-3.33
MetaVia Inc. (MTVA)United States$0.011B-0.65
Moleculin Biotech, Inc. (MBRX)United States$0.011B
FibroBiologics, Inc. (FBLG)United States$0.009B-0.27
Alzamend Neuro, Inc. (ALZN)United States$0.009B
Traws Pharma, Inc. (TRAW)United States$0.009B-0.58
Dare Bioscience, Inc. (DARE)United States$0.011B